[Effect of arsenic trioxide on the expression of apoptosis-related genes in NB4 cells]

Xiao-Hui Zhang1, Yu Hu, Guan-Xin Shen

  • 1Institute of Hematology and People Hospital, Peking University, Beijing 100044, China.

Insights

Arsenic trioxide treatment of acute promyelocytic leukemia (APL) cells altered gene expression, down-regulating key apoptosis and signal transduction genes. Specific genes like p21 and survivin may drive As2O3-induced NB4 cell apoptosis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Acute promyelocytic leukemia (APL) is a distinct subtype of leukemia.
  • Arsenic trioxide (As2O3) is a known therapeutic agent for APL.
  • Understanding the molecular mechanisms of As2O3 action is crucial for APL treatment.

Purpose of the Study:

  • To investigate the gene expression profiles of the NB4 APL cell line after As2O3 treatment.
  • To identify specific genes involved in As2O3-induced differentiation and apoptosis in NB4 cells.

Main Methods:

  • Utilized cDNA microarray technology to analyze gene expression.
  • Prepared cDNA probes from mRNA of NB4 cells treated with or without As2O3.
  • Hybridized probes to a microarray representing 201 human genes and scanned fluorescent intensities.

Main Results:

  • Identified significant changes in gene expression following As2O3 treatment (2 micromol/L).
  • Observed upregulation of 6 genes and downregulation of 12 genes.
  • Highlighted downregulation of genes related to apoptosis and signal transduction.

Conclusions:

  • The genes p21, survivin, cdc2, and Wee1Hu were identified as potentially involved in As2O3-induced differentiation and/or apoptosis of NB4 cells.
  • These genes may play a critical role in the underlying mechanism of arsenic trioxide-mediated apoptosis in APL.